Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1998
08/11/1998US5792609 Nucleotide fragment used to distinguish types of malaria from one another by hybridizing to dna sample
08/11/1998US5792607 Specific hybridization of probe/primer end so that the probability of the probe/primer contributing to spurious signal development is greatly reduced
08/11/1998US5792604 Introducing antigen into donor cell, incubating with primed cytotoxic t lymphocytes, measuring detectable marker released into medium
08/11/1998US5792467 Repellent compositions containing aromatic aldehydes
08/11/1998US5792463 Hybrid particle immunogens
08/11/1998US5792462 Alphavirus RNA replicon systems
08/11/1998US5792459 HIV-1 envelope muteins lacking hypervariable domains
08/11/1998US5792456 Mutant BR96 antibodies reactive with human carcinomas
08/11/1998US5792453 Transfecting cells in coronary arteries by injection of a transgene-inserted replication-deficit adenovirus; antiischemic agents; cardiotonic agents; vascular disease
08/11/1998CA1339992C Anticoagulant polypeptede
08/11/1998CA1339991C Replicative rna-based amplification/detection system
08/10/1998CA2223008A1 Def1
08/10/1998CA2222998A1 Def2
08/07/1998CA2228816A1 Ferulic acid decarboxylase
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/07/1998CA2222957A1 Novel histidine kinase
08/06/1998WO1998034121A2 Isolated p27 protein and methods for its production and use
08/06/1998WO1998034120A1 Protein fragment complementation assays to detect biomolecular interactions
08/06/1998WO1998034110A1 In situ identification of target structures e.g. in vivo selection method for a phage library
08/06/1998WO1998033942A1 Diagnosis and treatment of myocardial failure
08/06/1998WO1998033932A1 Lipid emulsions as gene transfection agents and method of preparing said emulsions
08/06/1998WO1998033930A1 A method for the production of dicarboxylic acids
08/06/1998WO1998033929A2 Use of a polypeptide as cell receptor for adenoviruses
08/06/1998WO1998033928A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector
08/06/1998WO1998033927A1 Genetically transformed plants demonstrating resistance to porphyrinogen biosynthesis-inhibiting herbicides
08/06/1998WO1998033926A1 Reagents and methods useful for detecting diseases of the lung
08/06/1998WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998WO1998033924A1 O-fucosyltransferase
08/06/1998WO1998033922A1 The neurotrophic factor nnt-1
08/06/1998WO1998033921A1 Novel human cystatin-like protein
08/06/1998WO1998033920A2 Tissue factor pathway inhibitor-3
08/06/1998WO1998033919A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998WO1998033918A1 Morphogenic proteins
08/06/1998WO1998033917A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998033915A1 Breast cancer specific gene 1
08/06/1998WO1998033914A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998WO1998033913A1 Human integral membrane protein
08/06/1998WO1998033912A1 MYELIN OLIGODENDROCYTE GLYCOPROTEIN-LIKE PROTEIN (MOGp) AND METHODS OF USE
08/06/1998WO1998033911A1 Human signal transduction protein regulating the nuclear movement
08/06/1998WO1998033910A1 Novel proline-rich membrane protein
08/06/1998WO1998033909A1 Novel human atpase inhibitor protein
08/06/1998WO1998033908A1 Human c5a-like receptor
08/06/1998WO1998033907A1 A tumor suppressor designated ts10q23.3
08/06/1998WO1998033906A1 Insecticidal gene and peptide
08/06/1998WO1998033905A1 K-atp channels, materials and methods relating to cell membrane proteins
08/06/1998WO1998033904A2 An antisense oligonucleotide preparation method
08/06/1998WO1998033903A1 Tissue specific promoters
08/06/1998WO1998033901A2 Generation of diversity in combinatorial libraries
08/06/1998WO1998033900A1 Method and apparatus for predicting protein function site, method for improving protein function, and function-improved protein
08/06/1998WO1998033899A1 Knockout animals
08/06/1998WO1998033896A2 Microorganisms with increased production of clavulanic acid
08/06/1998WO1998033895A1 A thermostable endo-beta-1,4-glucanase
08/06/1998WO1998033893A2 Ribozymes cleaving epidermal growth factor receptors
08/06/1998WO1998033891A1 Method for the production of selected lymphocytes
08/06/1998WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998WO1998033887A1 Growth differentiation factor-8
08/06/1998WO1998033884A1 Renibacterium salmoninarum vaccine
08/06/1998WO1998033819A1 Cellular receptors for subgroup c adenoviruses and group b coxsackieviruses
08/06/1998WO1998033818A1 Human anion channel
08/06/1998WO1998033817A1 Human membrane protein
08/06/1998WO1998033816A1 Nucleic acid encoding an acetyl-coenzyme-a transporter protein
08/06/1998WO1998033815A1 Amyloid beta protein (globular assembly and uses thereof)
08/06/1998WO1998033808A2 A reversible stoichiometric process for conjugating biomolecules
08/06/1998WO1998033807A1 Anti-viral guanosine-rich tetrad forming oligonucleotides
08/06/1998WO1998033529A1 Treatment for urinary incontinence using gene therapy techniques
08/06/1998WO1998033527A2 Cancer immunotherapy with semi-allogeneic cells
08/06/1998WO1998033519A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
08/06/1998WO1998033518A1 Mutants of thymidylate synthase and uses thereof
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998033510A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998WO1998033478A2 Rna- and dna-based active agents in nanoparticles
08/06/1998WO1998033387A1 Tolerance to natural antibody antigens
08/06/1998WO1998033379A1 A novel method for treating epidermal or dermal conditions
08/06/1998WO1998027116A3 Protein binding fragments of gravin
08/06/1998WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents
08/06/1998WO1998024813A3 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives
08/06/1998WO1998022587A3 Pituitary-tumor-transforming-genes, and related products
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998020034A3 Novel serine protease inhibitor nucleic acid molecules, proteins and uses thereof
08/06/1998WO1998017317A3 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
08/06/1998WO1998016645A3 Compounds and methods for diagnosis of tuberculosis
08/06/1998CA2284463A1 A reversible stoichiometric process for conjugating biomolecules
08/06/1998CA2280229A1 Breast cancer specific gene 1
08/06/1998CA2279991A1 Human anion channel
08/06/1998CA2279579A1 Insecticidal gene and peptide
08/06/1998CA2279577A1 Treatment for urinary incontinence using gene therapy techniques
08/06/1998CA2279552A1 Tissue specific promoters
08/06/1998CA2279551A1 Reagents and methods useful for detecting diseases of the lung
08/06/1998CA2279548A1 Ribozymes cleaving epidermal growth factor receptors
08/06/1998CA2279547A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998CA2279542A1 Tolerance to natural antibody antigens
08/06/1998CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998CA2279488A1 Anti-viral guanosine-rich tetrad forming oligonucleotides
08/06/1998CA2279487A1 Knockout animals
08/06/1998CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use